NAMS 2019 Annual Meeting Evaluation

Question Title

* 1. Please rate the level to which the learning objectives for the 2019 Annual Meeting were met.

	Not At All Met	Poorly Met	Somewhat Met	Mostly Met	Completely Met
Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause	Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause Not At All Met	Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause Poorly Met	Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause Somewhat Met	Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause Mostly Met	Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause Completely Met
Identify strategies to address practitioner stress and burnout	Identify strategies to address practitioner stress and burnout Not At All Met	Identify strategies to address practitioner stress and burnout Poorly Met	Identify strategies to address practitioner stress and burnout Somewhat Met	Identify strategies to address practitioner stress and burnout Mostly Met	Identify strategies to address practitioner stress and burnout Completely Met
Become familiar with the clinical dilemmas and concerns of progesterone and progestins at midlife	Become familiar with the clinical dilemmas and concerns of progesterone and progestins at midlife Not At All Met	Become familiar with the clinical dilemmas and concerns of progesterone and progestins at midlife Poorly Met	Become familiar with the clinical dilemmas and concerns of progesterone and progestins at midlife Somewhat Met	Become familiar with the clinical dilemmas and concerns of progesterone and progestins at midlife Mostly Met	Become familiar with the clinical dilemmas and concerns of progesterone and progestins at midlife Completely Met
Understand the history of hormone therapy, what studies have taught us, and the current role of hormones	Understand the history of hormone therapy, what studies have taught us, and the current role of hormones Not At All Met	Understand the history of hormone therapy, what studies have taught us, and the current role of hormones Poorly Met	Understand the history of hormone therapy, what studies have taught us, and the current role of hormones Somewhat Met	Understand the history of hormone therapy, what studies have taught us, and the current role of hormones Mostly Met	Understand the history of hormone therapy, what studies have taught us, and the current role of hormones Completely Met
Evaluate and review the outcomes of the VITamin D and OmegA-3 Trial (VITAL)	Evaluate and review the outcomes of the VITamin D and OmegA-3 Trial (VITAL) Not At All Met	Evaluate and review the outcomes of the VITamin D and OmegA-3 Trial (VITAL) Poorly Met	Evaluate and review the outcomes of the VITamin D and OmegA-3 Trial (VITAL) Somewhat Met	Evaluate and review the outcomes of the VITamin D and OmegA-3 Trial (VITAL) Mostly Met	Evaluate and review the outcomes of the VITamin D and OmegA-3 Trial (VITAL) Completely Met
Understand the prevention and screening options for colorectal and breast cancer	Understand the prevention and screening options for colorectal and breast cancer Not At All Met	Understand the prevention and screening options for colorectal and breast cancer Poorly Met	Understand the prevention and screening options for colorectal and breast cancer Somewhat Met	Understand the prevention and screening options for colorectal and breast cancer Mostly Met	Understand the prevention and screening options for colorectal and breast cancer Completely Met
Review the issues surrounding hormones and the brain, including depression and psychological outcomes	Review the issues surrounding hormones and the brain, including depression and psychological outcomes Not At All Met	Review the issues surrounding hormones and the brain, including depression and psychological outcomes Poorly Met	Review the issues surrounding hormones and the brain, including depression and psychological outcomes Somewhat Met	Review the issues surrounding hormones and the brain, including depression and psychological outcomes Mostly Met	Review the issues surrounding hormones and the brain, including depression and psychological outcomes Completely Met
Manage bone health and evaluate individualized treatment options	Manage bone health and evaluate individualized treatment options Not At All Met	Manage bone health and evaluate individualized treatment options Poorly Met	Manage bone health and evaluate individualized treatment options Somewhat Met	Manage bone health and evaluate individualized treatment options Mostly Met	Manage bone health and evaluate individualized treatment options Completely Met
Define the effect of trauma on women’s health and engage traumatized women in their healthcare	Define the effect of trauma on women’s health and engage traumatized women in their healthcare Not At All Met	Define the effect of trauma on women’s health and engage traumatized women in their healthcare Poorly Met	Define the effect of trauma on women’s health and engage traumatized women in their healthcare Somewhat Met	Define the effect of trauma on women’s health and engage traumatized women in their healthcare Mostly Met	Define the effect of trauma on women’s health and engage traumatized women in their healthcare Completely Met

Question Title

* 2. Please rate your ability to apply the learning objectives BEFORE the 2019 Annual Meeting and AFTER the 2019 Annual Meeting.

	Very Poor	Poor	Fair	Good	Excellent
BEFORE the 2019 Annual Meeting	BEFORE the 2019 Annual Meeting Very Poor	BEFORE the 2019 Annual Meeting Poor	BEFORE the 2019 Annual Meeting Fair	BEFORE the 2019 Annual Meeting Good	BEFORE the 2019 Annual Meeting Excellent
AFTER the 2019 Annual Meeting	AFTER the 2019 Annual Meeting Very Poor	AFTER the 2019 Annual Meeting Poor	AFTER the 2019 Annual Meeting Fair	AFTER the 2019 Annual Meeting Good	AFTER the 2019 Annual Meeting Excellent

Question Title

* 3. What changes will you make in your practice as a result of attending the 2019 Annual Meeting?

Question Title

* 4. Was the 2019 Annual Meeting fair, balanced, and free of commercial bias?

Yes

No - please indicate why not

Question Title

* 5. Please rate the level to which the 2019 Plenary Symposia

	Actively engaged you in the learning process	Provided you with usable ideas and/or techniques	Selected faculty with sufficient expertise on the topic
Plenary #1—Progestogens: A Necessary Evil?—Liu, Rubinow, Mesiano	Plenary #1—Progestogens: A Necessary Evil?—Liu, Rubinow, Mesiano Actively engaged you in the learning process menu	Plenary #1—Progestogens: A Necessary Evil?—Liu, Rubinow, Mesiano Provided you with usable ideas and/or techniques menu	Plenary #1—Progestogens: A Necessary Evil?—Liu, Rubinow, Mesiano Selected faculty with sufficient expertise on the topic menu
Plenary #2—Hormone Therapy—Utian, Miller, Pinkerton	Plenary #2—Hormone Therapy—Utian, Miller, Pinkerton Actively engaged you in the learning process menu	Plenary #2—Hormone Therapy—Utian, Miller, Pinkerton Provided you with usable ideas and/or techniques menu	Plenary #2—Hormone Therapy—Utian, Miller, Pinkerton Selected faculty with sufficient expertise on the topic menu
Plenary #3—Hormones and the Brain—Maki, Hickey	Plenary #3—Hormones and the Brain—Maki, Hickey Actively engaged you in the learning process menu	Plenary #3—Hormones and the Brain—Maki, Hickey Provided you with usable ideas and/or techniques menu	Plenary #3—Hormones and the Brain—Maki, Hickey Selected faculty with sufficient expertise on the topic menu
Plenary #4—Lessons From the VITamin D and OmegA-3 Trial (VITAL)—Manson, Okereke	Plenary #4—Lessons From the VITamin D and OmegA-3 Trial (VITAL)—Manson, Okereke Actively engaged you in the learning process menu	Plenary #4—Lessons From the VITamin D and OmegA-3 Trial (VITAL)—Manson, Okereke Provided you with usable ideas and/or techniques menu	Plenary #4—Lessons From the VITamin D and OmegA-3 Trial (VITAL)—Manson, Okereke Selected faculty with sufficient expertise on the topic menu
Plenary #5—Osteoporosis—Watts, McClung	Plenary #5—Osteoporosis—Watts, McClung Actively engaged you in the learning process menu	Plenary #5—Osteoporosis—Watts, McClung Provided you with usable ideas and/or techniques menu	Plenary #5—Osteoporosis—Watts, McClung Selected faculty with sufficient expertise on the topic menu
Plenary #6—Women and Their Microbes—Gilbert, Mitchell	Plenary #6—Women and Their Microbes—Gilbert, Mitchell Actively engaged you in the learning process menu	Plenary #6—Women and Their Microbes—Gilbert, Mitchell Provided you with usable ideas and/or techniques menu	Plenary #6—Women and Their Microbes—Gilbert, Mitchell Selected faculty with sufficient expertise on the topic menu
Plenary #7—Prevention and Screening—Yoshida, Mussallem	Plenary #7—Prevention and Screening—Yoshida, Mussallem Actively engaged you in the learning process menu	Plenary #7—Prevention and Screening—Yoshida, Mussallem Provided you with usable ideas and/or techniques menu	Plenary #7—Prevention and Screening—Yoshida, Mussallem Selected faculty with sufficient expertise on the topic menu
Plenary #8—Health Outcomes of Lifestyle and Prevention—Newman, Michos	Plenary #8—Health Outcomes of Lifestyle and Prevention—Newman, Michos Actively engaged you in the learning process menu	Plenary #8—Health Outcomes of Lifestyle and Prevention—Newman, Michos Provided you with usable ideas and/or techniques menu	Plenary #8—Health Outcomes of Lifestyle and Prevention—Newman, Michos Selected faculty with sufficient expertise on the topic menu
Plenary #9—Genitourinary Syndrome of Menopause—Goldstein, Haefner	Plenary #9—Genitourinary Syndrome of Menopause—Goldstein, Haefner Actively engaged you in the learning process menu	Plenary #9—Genitourinary Syndrome of Menopause—Goldstein, Haefner Provided you with usable ideas and/or techniques menu	Plenary #9—Genitourinary Syndrome of Menopause—Goldstein, Haefner Selected faculty with sufficient expertise on the topic menu
Plenary #10—The Effect of Trauma on Women's Health—Lewis-O'Connor, Levy-Carrick	Plenary #10—The Effect of Trauma on Women's Health—Lewis-O'Connor, Levy-Carrick Actively engaged you in the learning process menu	Plenary #10—The Effect of Trauma on Women's Health—Lewis-O'Connor, Levy-Carrick Provided you with usable ideas and/or techniques menu	Plenary #10—The Effect of Trauma on Women's Health—Lewis-O'Connor, Levy-Carrick Selected faculty with sufficient expertise on the topic menu
Plenary #11—Top Things You Should Know	Plenary #11—Top Things You Should Know Actively engaged you in the learning process menu	Plenary #11—Top Things You Should Know Provided you with usable ideas and/or techniques menu	Plenary #11—Top Things You Should Know Selected faculty with sufficient expertise on the topic menu

Question Title

* 6. Please rate the level to which the 2019 Presentations and the Breakfast Sessions

	Actively engaged you in the learning process	Provided you with usable ideas and/or techniques	Selected faculty with sufficient expertise on the topic
Keynote—Practitioner Stress and Burnout—Gautam	Keynote—Practitioner Stress and Burnout—Gautam Actively engaged you in the learning process menu	Keynote—Practitioner Stress and Burnout—Gautam Provided you with usable ideas and/or techniques menu	Keynote—Practitioner Stress and Burnout—Gautam Selected faculty with sufficient expertise on the topic menu
Utian Endowed—The New Frontier: Averting Menopause at 22 for Pediatric Cancer Survivors—Woodruff	Utian Endowed—The New Frontier: Averting Menopause at 22 for Pediatric Cancer Survivors—Woodruff Actively engaged you in the learning process menu	Utian Endowed—The New Frontier: Averting Menopause at 22 for Pediatric Cancer Survivors—Woodruff Provided you with usable ideas and/or techniques menu	Utian Endowed—The New Frontier: Averting Menopause at 22 for Pediatric Cancer Survivors—Woodruff Selected faculty with sufficient expertise on the topic menu
Kleinman Endowed—Women, Ethics, and Cannibinoids—Ayonrinde	Kleinman Endowed—Women, Ethics, and Cannibinoids—Ayonrinde Actively engaged you in the learning process menu	Kleinman Endowed—Women, Ethics, and Cannibinoids—Ayonrinde Provided you with usable ideas and/or techniques menu	Kleinman Endowed—Women, Ethics, and Cannibinoids—Ayonrinde Selected faculty with sufficient expertise on the topic menu
Scientific Abstract Sessions	Scientific Abstract Sessions Actively engaged you in the learning process menu	Scientific Abstract Sessions Provided you with usable ideas and/or techniques menu	Scientific Abstract Sessions Selected faculty with sufficient expertise on the topic menu
Canadian Leadership Session	Canadian Leadership Session Actively engaged you in the learning process menu	Canadian Leadership Session Provided you with usable ideas and/or techniques menu	Canadian Leadership Session Selected faculty with sufficient expertise on the topic menu
Updates from the MsFLASH Clinical Trials Network	Updates from the MsFLASH Clinical Trials Network Actively engaged you in the learning process menu	Updates from the MsFLASH Clinical Trials Network Provided you with usable ideas and/or techniques menu	Updates from the MsFLASH Clinical Trials Network Selected faculty with sufficient expertise on the topic menu
Mexican Leadership Session	Mexican Leadership Session Actively engaged you in the learning process menu	Mexican Leadership Session Provided you with usable ideas and/or techniques menu	Mexican Leadership Session Selected faculty with sufficient expertise on the topic menu
International Menopause Society Session	International Menopause Society Session Actively engaged you in the learning process menu	International Menopause Society Session Provided you with usable ideas and/or techniques menu	International Menopause Society Session Selected faculty with sufficient expertise on the topic menu
Thursday Breakfast Sessions	Thursday Breakfast Sessions Actively engaged you in the learning process menu	Thursday Breakfast Sessions Provided you with usable ideas and/or techniques menu	Thursday Breakfast Sessions Selected faculty with sufficient expertise on the topic menu
Friday Breakfast Sessions	Friday Breakfast Sessions Actively engaged you in the learning process menu	Friday Breakfast Sessions Provided you with usable ideas and/or techniques menu	Friday Breakfast Sessions Selected faculty with sufficient expertise on the topic menu

Question Title

* 7. Please select the topics that would benefit you in your professional practices.

Anorgasmia

Arthritis/Rheumatology

Brain health

Cancers (breast, cervical, uterine, etc)

Cardiovascular health

Chronic pelvic pain--gynecologic (vulvodynia, endometriosis, etc)

Cognition

Complementary and alternative medicine

Compounded hormones

Depression/Mood

Diabetes

Genitourinary syndrome of menopause

Hair/Skin

Headache/Migraines

Hot flashes

HT benefits/risks

Lifestyle modifications

Nonhormone options

Osteoporosis/Bone

Primary ovarian insufficiency

Sexual function

Sleep problems

Urinary incontinence

VMS hormone therapy

VMS nonhormone therapy

Weight loss/Obesity

Other (please specify)

Question Title

* 1. Please rate the level to which the learning objectives for the 2019 Annual Meeting were met.

Question Title

* 2. Please rate your ability to apply the learning objectives BEFORE the 2019 Annual Meeting and AFTER the 2019 Annual Meeting.

Question Title

* 3. What changes will you make in your practice as a result of attending the 2019 Annual Meeting?

Question Title

* 4. Was the 2019 Annual Meeting fair, balanced, and free of commercial bias?

Question Title

* 5. Please rate the level to which the 2019 Plenary Symposia

Question Title

* 6. Please rate the level to which the 2019 Presentations and the Breakfast Sessions

Question Title

* 7. Please select the topics that would benefit you in your professional practices.

Question Title

* 8. What is your profession?